Greco Theresa
SEC CIK 1998771 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| OPRX | OptimizeRx Corp | Chief Commercial Off | 71.1K | — | — | 8 | 2023-11-01 | 2026-05-15 |
Most active insiders at OPRX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Silvestro Stephen L | CEO | — | $30.4K |
| 2 | Stelmakh Edward | Chief Fin, Strat Off | — | $18.8K |
| 3 | Presti Mariyamma Varghese | Dir | — | — |
| 4 | Merrell Brendan W. | COO | — | — |
| 5 | D'Silva Andrew J. | Chief Business Off | — | — |
| 6 | Greco Theresa | Chief Commercial Off | — | — |
| 7 | Besch Doug | Chief Product, Tech Off | — | — |
| 8 | Odence-Ford Marion | Chief Legal, Admin Off | — | — |
| 9 | Lang James Paul | Dir | — | — |
| 10 | Vos Ellen O'Connor | Dir | — | — |
Transactions 8
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-05-18 16:44 | 2026-05-15 | OPRX | OptimizeRx Corp | Greco Theresa | Chief Commercial Off | F - Tax | $5.21 | -1,793 | 71.1K | -2% | -$9,342 |
| 2025-12-23 | 2025-12-23 | OPRX | OptimizeRx Corp | Greco Theresa | Chief Commercial Off | F - Tax | $12.74 | -1,420 | 72.9K | -2% | -$18.1K | |
| 2025-11-03 | 2025-11-01 | OPRX | OptimizeRx Corp | Greco Theresa | Chief Commercial Off | F - Tax | $20.49 | -1,693 | 74.3K | -2% | -$34.7K | |
| D | 2025-08-25 | 2025-08-21 | OPRX | OptimizeRx Corp | Greco Theresa | Chief Commercial Off | A - Grant | $0.00 | +15.6K | 76.0K | +26% | $0 |
| DM | 2025-05-19 | 2025-05-15 | OPRX | OptimizeRx Corp | Greco Theresa | Chief Commercial Off | A - Grant | $0.00 | +9,483 | 60.4K | +19% | $0 |
| D | 2024-12-27 | 2024-12-23 | OPRX | OptimizeRx Corp | Greco Theresa | Chief Commercial Off | A - Grant | $0.00 | +15.5K | 50.9K | +44% | $0 |
| 2024-11-05 | 2024-11-01 | OPRX | OptimizeRx Corp | Greco Theresa | Chief Commercial Off | F - Tax | $5.15 | -1,693 | 35.3K | -5% | -$8,719 | |
| D | 2023-11-03 | 2023-11-01 | OPRX | OptimizeRx Corp | Greco Theresa | Chief Commercial Off | A - Grant | $0.00 | +18.5K | 37.0K | +100% | $0 |
Purchase Sale Sale after option exercise All abbreviations